secwatch.observer — SEC 8-K summary
======================================

Issuer:     GRAIL, Inc. (GRAL)
CIK:        0001699031
Form:       8-K
Filed at:   2024-11-12T23:59:59+00:00
Accession:  0001628280-24-047100
Event type: earnings
Sentiment:  negative
Materiality: 0.70
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

GRAIL Q3 2024: Galleri revenue $25.4M (+52% YoY); net loss $(125.7)M
--------------------------------------------------------------------

- Total revenue $28.7M (+38% YoY); Galleri revenue $25.4M (+52% YoY).
- Net loss $(125.7)M includes $34.6M amortization and $19.0M restructuring charge.
- Non-GAAP adjusted EBITDA $(108.2)M, improved 14% YoY; adjusted gross profit $11.8M.
- Cash $853.6M, runway into 2028; commercial Galleri tests surpassed 250,000 since launch.
- CEO Bob Ragusa highlighted cost management and progress toward FDA PMA submission.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1699031/000162828024047100/0001628280-24-047100-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1699031/000162828024047100/gral-20241112.htm
  HTML page:      https://secwatch.observer/filing/0001628280-24-047100

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer